Boban D, Sucić M, Marković-Glamocak M, Uzarević B, Batinić D, Marusić M, Nemet D, Labar B, Hitrec V
Department of Clinical Laboratory Diagnosis, Lagreb University School of Medicine and Clinical Center, Croatia.
Eur J Cancer. 1993;29A(8):1167-72. doi: 10.1016/s0959-8049(05)80309-0.
Correlation between the FAB classification and immunophenotype was studied in 169 consecutive adult patients with acute leukaemia (AL). The lineage of leukaemic cells could be determined in the majority of cases, whereas 3 patients (1.8%) remained unclassified. In 22 out of 71 patients (31%) with acute myeloid leukaemia (AML) FAB M1 and M2 types, and in 5 out of 16 patients (31%) with chronic myeloid leukaemia (CML) in myeloid blast crisis, leukaemic cells did not express myeloid lineage-related markers, indicating asynchronous expression of cell markers in a substantial proportion of patients. Flow cytometric two-colour immunofluorescence revealed mixed AL immunophenotype in 6 out of 169 patients (3.4%). This group included five CD2+AML (5% of AML tested) and one undifferentiated AL expressing CD10(CALLA), CDw65(VIM-2). The former group included FAB M1, M2, M3 and M4 forms of AML with a single cell population, and an AML M2 patient with both cytochemically and immunologically two separate populations of leukaemic cells. This further illustrates the heterogeneity of the target cell(s) for leukaemogenesis and the level of differentiation of AML cells. However, there was no difference in the treatment response and the remission duration between AML patients and patients with mixed phenotype AML.
对169例连续性成年急性白血病(AL)患者进行了FAB分型与免疫表型之间相关性的研究。大多数情况下可确定白血病细胞的谱系,然而有3例患者(1.8%)仍无法分类。在71例急性髓系白血病(AML)FAB M1和M2型患者中的22例(31%),以及16例处于髓系原始细胞危象的慢性髓系白血病(CML)患者中的5例(31%),白血病细胞未表达髓系谱系相关标志物,表明相当一部分患者中细胞标志物存在异步表达。流式细胞术双色免疫荧光显示169例患者中有6例(3.4%)存在混合性AL免疫表型。该组包括5例CD2+AML(占检测AML的5%)和1例表达CD10(CALLA)、CDw65(VIM-2)的未分化AL。前一组包括具有单一细胞群的FAB M1、M2、M3和M4型AML,以及1例在细胞化学和免疫学上均有两个独立白血病细胞群的AML M2患者。这进一步说明了白血病发生的靶细胞的异质性以及AML细胞的分化水平。然而,AML患者与混合表型AML患者之间的治疗反应和缓解持续时间并无差异。